Acute Leukemias:
The new edition of this well-received book provides a timely update of current knowledge on the biology, disease classification, and treatment of the acute leukemias - acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Throughout, the focus is on the provision of state of the art i...
Gespeichert in:
| Weitere Verfasser: | , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Cham
Springer International Publishing
2021
|
| Ausgabe: | 2nd edition |
| Schriftenreihe: | Hematologic Malignancies
|
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | The new edition of this well-received book provides a timely update of current knowledge on the biology, disease classification, and treatment of the acute leukemias - acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Throughout, the focus is on the provision of state of the art information and guidance that will meet the needs of clinicians. Chapters have been extensively revised to take into account advances in understanding and management that have been achieved over the past few years. In addition, new chapters have been included on selection of AML patients for therapy, a broader discussion of stem cell transplantation in AML, the role of immunotherapy in ALL, the approach to newly diagnosed pediatric ALL, and the diagnosis and management of BCR-ABL-like ALL. New therapies, including investigational ones, are fully covered. As progress continues in the management of acute leukemias this book will be a valuable asset for clinicians at all levels of experience |
| Beschreibung: | Part I Acute Myeloid Leukemia -- Acute Myeloid Leukemia: Epidemiology and Etiology -- Clinical Presentation, Diagnosis and Classification of Acute Myedloid Leukemia -- Selection of Patients for Therapy -- Therapy of Newly Diagnosed AML -- Management of Relapsed and Refractory AML -- Stem cell Transplant in AML -- Investigational Therapies in AML -- Acute Lymphoblastic Leukemia -- Acute Lymphoblastic Leukemia: Epidemiology abnd Etiology -- Molecular Biology and Genetics -- Acute Lymphoblastic Leukemia: Clinical Presentation, Diagnosis, and Classification -- Therapy of Newly Diagnosed Adult ALL -- Approach to Newly Diagnosed Pediatric and AYA ALL -- The Role of Immunotherapy in ALL -- STem Cell Transplantation in the Treatment of ALL -- The Significance of Minimal Residual Disease in Acute Lymphoblastic Leukemia -- Philadelphia Chromosome - Positive Acute Lymphoblastic Leukemia -- BCR-ABL-like ALL: Diagnosis and Management -- Burkitt's Acute Lymphoblastic Leukema in Adults -- Treatment of Lymphoblastic Lymphoma in Adults -- Central Nervous System Involovment in Adult Acute Lymphocytic Leukemia -- Management of Relapsed and Refractory ALL -- Emergencies in Acute Lymphoblastic Leukema -- Investigational Therapies in ALL. |
| Beschreibung: | 1 Online-Ressource (VI, 289 Seiten) Illustrationen |
| ISBN: | 9783030536336 |
| DOI: | 10.1007/978-3-030-53633-6 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046997617 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 201113s2021 |||| o||u| ||||||eng d | ||
| 020 | |a 9783030536336 |9 978-3-030-53633-6 | ||
| 024 | 7 | |a 10.1007/978-3-030-53633-6 |2 doi | |
| 035 | |a (ZDB-2-SME)978-3-030-53633-6 | ||
| 035 | |a (OCoLC)1220904516 | ||
| 035 | |a (DE-599)BVBBV046997617 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-578 | ||
| 082 | 0 | |a 616.994 | |
| 245 | 1 | 0 | |a Acute Leukemias |c edited by Stefan H. Faderl, Hagop M. Kantarjian, Elihu Estey |
| 250 | |a 2nd edition | ||
| 264 | 1 | |a Cham |b Springer International Publishing |c 2021 | |
| 300 | |a 1 Online-Ressource (VI, 289 Seiten) |b Illustrationen | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Hematologic Malignancies | |
| 500 | |a Part I Acute Myeloid Leukemia -- Acute Myeloid Leukemia: Epidemiology and Etiology -- Clinical Presentation, Diagnosis and Classification of Acute Myedloid Leukemia -- Selection of Patients for Therapy -- Therapy of Newly Diagnosed AML -- Management of Relapsed and Refractory AML -- Stem cell Transplant in AML -- Investigational Therapies in AML -- Acute Lymphoblastic Leukemia -- Acute Lymphoblastic Leukemia: Epidemiology abnd Etiology -- Molecular Biology and Genetics -- Acute Lymphoblastic Leukemia: Clinical Presentation, Diagnosis, and Classification -- Therapy of Newly Diagnosed Adult ALL -- Approach to Newly Diagnosed Pediatric and AYA ALL -- The Role of Immunotherapy in ALL -- STem Cell Transplantation in the Treatment of ALL -- The Significance of Minimal Residual Disease in Acute Lymphoblastic Leukemia -- Philadelphia Chromosome - Positive Acute Lymphoblastic Leukemia -- BCR-ABL-like ALL: Diagnosis and Management -- Burkitt's Acute Lymphoblastic Leukema in Adults -- Treatment of Lymphoblastic Lymphoma in Adults -- Central Nervous System Involovment in Adult Acute Lymphocytic Leukemia -- Management of Relapsed and Refractory ALL -- Emergencies in Acute Lymphoblastic Leukema -- Investigational Therapies in ALL. | ||
| 520 | |a The new edition of this well-received book provides a timely update of current knowledge on the biology, disease classification, and treatment of the acute leukemias - acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Throughout, the focus is on the provision of state of the art information and guidance that will meet the needs of clinicians. Chapters have been extensively revised to take into account advances in understanding and management that have been achieved over the past few years. In addition, new chapters have been included on selection of AML patients for therapy, a broader discussion of stem cell transplantation in AML, the role of immunotherapy in ALL, the approach to newly diagnosed pediatric ALL, and the diagnosis and management of BCR-ABL-like ALL. New therapies, including investigational ones, are fully covered. As progress continues in the management of acute leukemias this book will be a valuable asset for clinicians at all levels of experience | ||
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Hematology | |
| 700 | 1 | |a Faderl, Stefan H. |4 edt | |
| 700 | 1 | |a Kantarjian, Hagop M. |4 edt | |
| 700 | 1 | |a Estey, Elihu |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783030536329 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783030536343 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783030536350 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-030-53633-6 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME |a ZDB-2-SXM | ||
| 940 | 1 | |q ZDB-2-SME_2021_Fremddaten | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032405340 | ||
| 966 | e | |u https://doi.org/10.1007/978-3-030-53633-6 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_2021_Fremddaten |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804181944293916672 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author2 | Faderl, Stefan H. Kantarjian, Hagop M. Estey, Elihu |
| author2_role | edt edt edt |
| author2_variant | s h f sh shf h m k hm hmk e e ee |
| author_facet | Faderl, Stefan H. Kantarjian, Hagop M. Estey, Elihu |
| building | Verbundindex |
| bvnumber | BV046997617 |
| collection | ZDB-2-SME ZDB-2-SXM |
| ctrlnum | (ZDB-2-SME)978-3-030-53633-6 (OCoLC)1220904516 (DE-599)BVBBV046997617 |
| dewey-full | 616.994 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.994 |
| dewey-search | 616.994 |
| dewey-sort | 3616.994 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| doi_str_mv | 10.1007/978-3-030-53633-6 |
| edition | 2nd edition |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03876nmm a2200469zc 4500</leader><controlfield tag="001">BV046997617</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">201113s2021 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783030536336</subfield><subfield code="9">978-3-030-53633-6</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-030-53633-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-030-53633-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1220904516</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046997617</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.994</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Acute Leukemias</subfield><subfield code="c">edited by Stefan H. Faderl, Hagop M. Kantarjian, Elihu Estey</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">2nd edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham</subfield><subfield code="b">Springer International Publishing</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (VI, 289 Seiten)</subfield><subfield code="b">Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Hematologic Malignancies</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Part I Acute Myeloid Leukemia -- Acute Myeloid Leukemia: Epidemiology and Etiology -- Clinical Presentation, Diagnosis and Classification of Acute Myedloid Leukemia -- Selection of Patients for Therapy -- Therapy of Newly Diagnosed AML -- Management of Relapsed and Refractory AML -- Stem cell Transplant in AML -- Investigational Therapies in AML -- Acute Lymphoblastic Leukemia -- Acute Lymphoblastic Leukemia: Epidemiology abnd Etiology -- Molecular Biology and Genetics -- Acute Lymphoblastic Leukemia: Clinical Presentation, Diagnosis, and Classification -- Therapy of Newly Diagnosed Adult ALL -- Approach to Newly Diagnosed Pediatric and AYA ALL -- The Role of Immunotherapy in ALL -- STem Cell Transplantation in the Treatment of ALL -- The Significance of Minimal Residual Disease in Acute Lymphoblastic Leukemia -- Philadelphia Chromosome - Positive Acute Lymphoblastic Leukemia -- BCR-ABL-like ALL: Diagnosis and Management -- Burkitt's Acute Lymphoblastic Leukema in Adults -- Treatment of Lymphoblastic Lymphoma in Adults -- Central Nervous System Involovment in Adult Acute Lymphocytic Leukemia -- Management of Relapsed and Refractory ALL -- Emergencies in Acute Lymphoblastic Leukema -- Investigational Therapies in ALL.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The new edition of this well-received book provides a timely update of current knowledge on the biology, disease classification, and treatment of the acute leukemias - acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Throughout, the focus is on the provision of state of the art information and guidance that will meet the needs of clinicians. Chapters have been extensively revised to take into account advances in understanding and management that have been achieved over the past few years. In addition, new chapters have been included on selection of AML patients for therapy, a broader discussion of stem cell transplantation in AML, the role of immunotherapy in ALL, the approach to newly diagnosed pediatric ALL, and the diagnosis and management of BCR-ABL-like ALL. New therapies, including investigational ones, are fully covered. As progress continues in the management of acute leukemias this book will be a valuable asset for clinicians at all levels of experience</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology </subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hematology</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Faderl, Stefan H.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kantarjian, Hagop M.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Estey, Elihu</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783030536329</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783030536343</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783030536350</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-030-53633-6</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield><subfield code="a">ZDB-2-SXM</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_2021_Fremddaten</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032405340</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-030-53633-6</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_2021_Fremddaten</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV046997617 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T15:55:37Z |
| indexdate | 2024-07-10T08:59:42Z |
| institution | BVB |
| isbn | 9783030536336 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032405340 |
| oclc_num | 1220904516 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-578 |
| owner_facet | DE-355 DE-BY-UBR DE-578 |
| physical | 1 Online-Ressource (VI, 289 Seiten) Illustrationen |
| psigel | ZDB-2-SME ZDB-2-SXM ZDB-2-SME_2021_Fremddaten ZDB-2-SME ZDB-2-SME_2021_Fremddaten |
| publishDate | 2021 |
| publishDateSearch | 2021 |
| publishDateSort | 2021 |
| publisher | Springer International Publishing |
| record_format | marc |
| series2 | Hematologic Malignancies |
| spelling | Acute Leukemias edited by Stefan H. Faderl, Hagop M. Kantarjian, Elihu Estey 2nd edition Cham Springer International Publishing 2021 1 Online-Ressource (VI, 289 Seiten) Illustrationen txt rdacontent c rdamedia cr rdacarrier Hematologic Malignancies Part I Acute Myeloid Leukemia -- Acute Myeloid Leukemia: Epidemiology and Etiology -- Clinical Presentation, Diagnosis and Classification of Acute Myedloid Leukemia -- Selection of Patients for Therapy -- Therapy of Newly Diagnosed AML -- Management of Relapsed and Refractory AML -- Stem cell Transplant in AML -- Investigational Therapies in AML -- Acute Lymphoblastic Leukemia -- Acute Lymphoblastic Leukemia: Epidemiology abnd Etiology -- Molecular Biology and Genetics -- Acute Lymphoblastic Leukemia: Clinical Presentation, Diagnosis, and Classification -- Therapy of Newly Diagnosed Adult ALL -- Approach to Newly Diagnosed Pediatric and AYA ALL -- The Role of Immunotherapy in ALL -- STem Cell Transplantation in the Treatment of ALL -- The Significance of Minimal Residual Disease in Acute Lymphoblastic Leukemia -- Philadelphia Chromosome - Positive Acute Lymphoblastic Leukemia -- BCR-ABL-like ALL: Diagnosis and Management -- Burkitt's Acute Lymphoblastic Leukema in Adults -- Treatment of Lymphoblastic Lymphoma in Adults -- Central Nervous System Involovment in Adult Acute Lymphocytic Leukemia -- Management of Relapsed and Refractory ALL -- Emergencies in Acute Lymphoblastic Leukema -- Investigational Therapies in ALL. The new edition of this well-received book provides a timely update of current knowledge on the biology, disease classification, and treatment of the acute leukemias - acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Throughout, the focus is on the provision of state of the art information and guidance that will meet the needs of clinicians. Chapters have been extensively revised to take into account advances in understanding and management that have been achieved over the past few years. In addition, new chapters have been included on selection of AML patients for therapy, a broader discussion of stem cell transplantation in AML, the role of immunotherapy in ALL, the approach to newly diagnosed pediatric ALL, and the diagnosis and management of BCR-ABL-like ALL. New therapies, including investigational ones, are fully covered. As progress continues in the management of acute leukemias this book will be a valuable asset for clinicians at all levels of experience Oncology Hematology Faderl, Stefan H. edt Kantarjian, Hagop M. edt Estey, Elihu edt Erscheint auch als Druck-Ausgabe 9783030536329 Erscheint auch als Druck-Ausgabe 9783030536343 Erscheint auch als Druck-Ausgabe 9783030536350 https://doi.org/10.1007/978-3-030-53633-6 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Acute Leukemias Oncology Hematology |
| title | Acute Leukemias |
| title_auth | Acute Leukemias |
| title_exact_search | Acute Leukemias |
| title_exact_search_txtP | Acute Leukemias |
| title_full | Acute Leukemias edited by Stefan H. Faderl, Hagop M. Kantarjian, Elihu Estey |
| title_fullStr | Acute Leukemias edited by Stefan H. Faderl, Hagop M. Kantarjian, Elihu Estey |
| title_full_unstemmed | Acute Leukemias edited by Stefan H. Faderl, Hagop M. Kantarjian, Elihu Estey |
| title_short | Acute Leukemias |
| title_sort | acute leukemias |
| topic | Oncology Hematology |
| topic_facet | Oncology Hematology |
| url | https://doi.org/10.1007/978-3-030-53633-6 |
| work_keys_str_mv | AT faderlstefanh acuteleukemias AT kantarjianhagopm acuteleukemias AT esteyelihu acuteleukemias |